IDH2 and glioblastoma: In the 2016 WHO classification, anaplastic astrocytomas were differentiated into IDH-mutant and IDH-wildtype; the latter, lacking the IDH mutation, had a significantly worse prognosis (behaving like glioblastoma) [9].